Literature DB >> 16817040

Polyneuropathy in hemodialysis patients: the most sensitive electrophysiological parameters and dialysis adequacy.

Tanja Hojs-Fabjan1, Radovan Hojs.   

Abstract

BACKGROUND: Polyneuropathy (PNP) is a common complication in hemodialysis (HD) patients. Electrophysiological parameters are quantitative indices of its severity. The aim of our study was to find the prevalence of pathologic electrophysiological parameters, to assess their prevalence in relation to duration of HD treatment and age, to establish which parameters are the most sensitive in demonstrating PNP and to find an association between them and HD adequacy. PATIENTS AND METHODS: We included 84 (50 men, 34 women) HD patients (average age 47.32 years; average dialysis duration 62.56 months) and divided them into three groups according to the duration of HD treatment. Each group was further divided into two subgroups according to age. We included electrophysiological parameters for evaluation of motor and sensory nerve functions (Medelec Sapphire Premiere device). HD adequacy was measured with urea kinetic modeling (Kt/V).
RESULTS: PNP was found in 77 (91.6%) HD patients and was more common in men (P < 0.016). The association between the number of pathologic electrophysiological parameters and age (P < 0.0001), duration of HD treatment (P < 0.009) and HD adequacy (P < 0.0001) was statistically significant. The most sensitive electrophysiological parameter was the latency of the F wave (pathologic values of F wave latency in the lower limbs in 86% patients and in the upper limbs in 49%). Sensory conduction velocities and the amplitudes of the orthodromic sensory action potentials and the M wave were also sensitive parameters. The F wave latency of different nerves was associated with dialysis adequacy.
CONCLUSIONS: PNP is frequent in HD patients and is associated with age and duration of dialysis treatment. The most sensitive electrophysiological parameter of PNP is F wave latency, which may also be used as a parameter of dialysis adequacy.

Entities:  

Mesh:

Year:  2006        PMID: 16817040     DOI: 10.1007/s00508-006-0547-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  21 in total

Review 1.  AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography.

Authors:  P D Donofrio; J W Albers
Journal:  Muscle Nerve       Date:  1990-10       Impact factor: 3.217

2.  F-waves in evaluating uremic polyneuropathy: a long-term study after the application of continuous ambulatory peritoneal dialysis.

Authors:  S Peioglou-Harmoussi; A Dimitriadis; S Antoniou; F Noitsi-Michali; J Logothetis
Journal:  Funct Neurol       Date:  1987 Apr-Jun

3.  The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity.

Authors:  V K Nielsen
Journal:  Acta Med Scand       Date:  1973-11

4.  Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study.

Authors:  P E Teschan; J R Bourne; R B Reed; J W Ward
Journal:  Kidney Int Suppl       Date:  1983-04       Impact factor: 10.545

Review 5.  Quantifying hemodialysis.

Authors:  T A Depner
Journal:  Am J Nephrol       Date:  1996       Impact factor: 3.754

6.  Electrophysiological course of uraemic neuropathy in haemodialysis patients.

Authors:  T Ogura; A Makinodan; T Kubo; T Hayashida; Y Hirasawa
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

Review 7.  Quantification of hemodialysis: analysis of methods and the relevance to patient outcome.

Authors:  W R Clark; M V Rocco; A J Collins
Journal:  Blood Purif       Date:  1997       Impact factor: 2.614

8.  The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies.

Authors:  J L Fraser; R K Olney
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

Review 9.  Nervous system complications in uremia.

Authors:  C L Fraser; A I Arieff
Journal:  Ann Intern Med       Date:  1988-07-15       Impact factor: 25.391

10.  Electrophysiological aspects of nervous conduction in uremia.

Authors:  B Di Paolo; T Di Marco; P Cappelli; C Spisni; G Del Rosso; P F Palmieri; M Evangelista; A Albertazzi
Journal:  Clin Nephrol       Date:  1988-05       Impact factor: 0.975

View more
  5 in total

1.  Restless legs syndrome in hemodialysis patients: association with depression and quality of life.

Authors:  Deniz Tuncel; Fatma Ozlem Orhan; Hayriye Sayarlioglu; Ismet Onder Isık; Uygar Utku; Aytac Dinc
Journal:  Sleep Breath       Date:  2010-07-01       Impact factor: 2.816

2.  A neurophysiological study of large- and small-diameter nerve fibers in the hands of hemodialysis patients.

Authors:  Miro Denislic; Merita Tiric-Campara; Halima Resić; Jasem Y Al-Hashel; Rok Zorec; Refet Gojak; Jan Ravnik
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

3.  Shear Wave Elastography in the Diagnosis of Peripheral Neuropathy in Patients With Chronic Kidney Disease Stage 5.

Authors:  Xuan Li; Haoqi Sun; Zhaoguang Zhang; Jing Liu; Huiying Xu; Lin Ma; Haibo Zhang; Jialin Li; Qian Luo; Xiangming Wang; Min Guo; Zhentao Guo; Xuexun Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

4.  Effects of hemodiafiltration and high flux hemodialysis on nerve excitability in end-stage kidney disease.

Authors:  Ria Arnold; Bruce A Pussell; Timothy J Pianta; Virginija Grinius; Cindy S-Y Lin; Matthew C Kiernan; James Howells; Meg J Jardine; Arun V Krishnan
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

5.  Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled Trial.

Authors:  Amy Kang; Ria Arnold; Martin Gallagher; Paul Snelling; Julianne Green; Mangalee Fernando; Matthew C Kiernan; Samantha Hand; Kim Grimley; Jenny Burman; Anne Heath; Kris Rogers; Amritendu Bhattacharya; Brendan Smyth; Thomas Bradbury; Carmel Hawley; Vlado Perkovic; Arun V Krishnan; Meg J Jardine
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-07       Impact factor: 10.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.